XML 149 R108.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock Incentive Plans - Stock Option and SAR Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Cash received from stock options exercised (including ESPP) $ 210,000 $ 242,000 $ 329,000
Payments for taxes for net share settlement of equity awards $ 112,000 97,000 71,000
Stock options granted prior to 2019      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expiration period 7 years    
Stock options granted in 2019      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expiration period 10 years    
Stock Appreciation Rights (SARs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expiration period 10 years    
Employee Stock Options and Stock Appreciation Rights      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Cash received from stock options exercised (including ESPP) $ 210,000 242,000 329,000
Payments for taxes for net share settlement of equity awards 112,000 97,000 71,000
Intrinsic value of stock options and SARs exercised 30,000 79,000 176,000
Fair value of stock options and SARs vested $ 467,000 $ 324,000 $ 341,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Shares, Outstanding at beginning of year (in shares) 22,909    
Shares granted (in shares) 6,538    
Shares exercised (in shares) (3,667)    
Shares forfeited (in shares) (769)    
Shares expired (in shares) (1,109)    
Shares, Outstanding at end of year (in shares) 23,902 22,909  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]      
Weighted average exercise price, outstanding at beginning of year ($ per share) $ 71.15    
Weighted average exercise price, granted ($ per share) 54.40    
Weighted average exercise price, exercised ($ per share) 46.17    
Weighted average exercise price, forfeited ($ per share) 68.12    
Weighted average exercise price, expired ($ per share) 82.40    
Weighted average exercise price, outstanding at end of year ($ per share) $ 69.98 $ 71.15  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Weighted average contractual term, outstanding at end of year 4 years 9 months 3 days    
Aggregate Intrinsic value outstanding at end of year $ 274,987    
Shares exercisable at end of year (in shares) 13,267    
Weighted average exercise price exercisable at end of year ($ per share) $ 77.48    
Weighted average remaining contractual term exercisable at end of year 2 years 8 months 23 days    
Aggregate intrinsic value exercisable at end of year $ 109,765    
Shares vested at end of year and expected to vest in the future (in shares) 23,328    
Weighted average exercise price vested at end of year and expected to vest in the future ($ per share) $ 70.28    
Weighted average remaining contractual term vested at end of year and expected to vest in the future 4 years 8 months 1 day    
Aggregate intrinsic value vested at end of year and expected to vest in the future $ 265,128